# MIER3

## Overview
MIER3 is a gene that encodes the protein MIER family member 3, which is part of the MIER family of transcriptional regulators. This protein is primarily localized in the nucleus and is involved in modulating gene expression through its interactions with other proteins, such as the transcription factor Sp1. MIER3 plays a significant role in cellular processes, particularly in the context of cancer biology, where it has been implicated as a potential tumor suppressor. It is known to influence epithelial-to-mesenchymal transition (EMT) and tumorigenesis, especially in colorectal cancer (CRC), by down-regulating Sp1 and inhibiting cancer progression (Peng2017MIER3). Although MIER3 is part of a family known for interactions with histone deacetylases (HDACs), it exhibits low levels of HDAC recruitment, suggesting a unique functional profile within its family (Derwish2017Differential). The gene's expression levels and interactions make it a potential prognostic marker and therapeutic target in CRC (Peng2017MIER3).

## Structure


## Clinical Significance
The MIER3 gene has been implicated in the progression of colorectal cancer (CRC). Research indicates that MIER3 functions as a potential tumor suppressor gene, with its expression significantly reduced in human primary colorectal cancer tissues. This down-regulation is associated with advanced disease stages, metastasis, and poor prognosis in CRC patients (Peng2017MIER3). Functional studies have demonstrated that increased expression of MIER3 in CRC cells inhibits cell proliferation, migration, and invasion, while its down-regulation promotes these aggressive cancer behaviors (Peng2017MIER3).

The tumor-suppressive effects of MIER3 are thought to be mediated through the down-regulation of Sp1, a transcription factor involved in epithelial-mesenchymal transition (EMT), a critical process for cancer metastasis. MIER3's interaction with Sp1 influences the expression of EMT-associated proteins, thereby inhibiting tumor progression (Peng2017MIER3). The clinical significance of MIER3 is underscored by its potential as a prognostic marker and therapeutic target in CRC, given its correlation with poor survival outcomes when expressed at low levels (Peng2017MIER3). However, the exact molecular mechanisms by which MIER3 exerts its effects remain to be fully elucidated (Peng2017MIER3).

## Interactions
MIER3, a member of the MIER family, is involved in various protein interactions that influence its function in cellular processes. It has been shown to interact with the transcription factor Sp1, which is involved in tumorigenesis and epithelial-to-mesenchymal transition (EMT). This interaction is significant in colorectal cancer (CRC) as MIER3 down-regulates Sp1, thereby inhibiting EMT and suppressing cancer progression (Peng2017MIER3).

MIER3 is also part of the MIER family known for interactions with histone deacetylases (HDACs), specifically HDAC1 and HDAC2. However, MIER3 shows low levels of HDAC recruitment compared to its family members MIER1 and MIER2, suggesting it may not function in HDAC recruitment under normal physiological conditions (Derwish2017Differential). This indicates that MIER3 might require additional factors or specific conditions to engage in HDAC interactions.

The protein is primarily localized in the nucleus, which aligns with its role in transcriptional regulation (Derwish2017Differential). Despite its limited interaction with HDACs, MIER3's involvement with Sp1 and its nuclear localization underscore its potential role in modulating gene expression and cellular behavior.


## References


[1. (Derwish2017Differential) Roya Derwish, Gary D. Paterno, and Laura L. Gillespie. Differential hdac1 and 2 recruitment by members of the mier family. PLOS ONE, 12(1):e0169338, January 2017. URL: http://dx.doi.org/10.1371/journal.pone.0169338, doi:10.1371/journal.pone.0169338. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0169338)

[2. (Peng2017MIER3) Man Peng, Yukun Hu, Wen Song, Shiyu Duan, Qiong Xu, Yanqing Ding, Jian Geng, and Jun Zhou. Mier3 suppresses colorectal cancer progression by down-regulating sp1, inhibiting epithelial-mesenchymal transition. Scientific Reports, September 2017. URL: http://dx.doi.org/10.1038/s41598-017-11374-y, doi:10.1038/s41598-017-11374-y. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-11374-y)